A new Candida parapsilosis lipase was isolated and studied. This enzyme was purified by hydrophobic chromatography on a phenyl-sepharose CIAB column followed by gel permeation on a Sephacryl $300 HR column. It was a 160 kg'mo1-1 molecular-weight oligomeric enzyme. Optimal activity was obtained at 45°C and pH 6.5. The lipase activity toward various acylglycerols and esters was studied. The hydrolysis rate was greater for secondary acylesters than for primary acylesters. This lipase showed a high specificity for long-chain fatty acids and particularly for polyunsaturated fatty acids. This enzyme was able to catalyze the synthesis of various oleoylesters in aqueous medium.
Jacalin is a plant lectin known to specifically induce the proliferation of CD4+ T lymphocytes in human. We demonstrate here that jacalin completely blocks human immunodeficiency virus type 1 (HIV-1) in vitro infection of lymphoid cells. Jacalin does not bind the viral envelope glycoprotein gp120. Besides other T cell surface molecules, it interacts with CD4, the high-affinity receptor to HIV. Binding of jacalin to CD4 does not prevent gp120-CD4 interaction and does not inhibit virus binding and syncytia formation. The anti-HIV effect of the native lectin can be reproduced by its separated alpha-subunits. More importantly, we have defined in the alpha-chain of jacalin a 14-amino acid sequence which shows high similarities with a peptide of the second conserved domain of gp120. A synthetic peptide corresponding to this similar stretch also exerts a potent anti-HIV effect. This peptide is not mitogenic for peripheral blood mononuclear cells and does not inhibit anti-CD3-induced lymphocyte proliferation. These results make jacalin alpha chain-derived peptide a potentially valuable therapeutic agent for acquired immunodeficiency syndrome.
An amidase with a wide activity spectrum was purified from the Brevibacterium sp. R 312 and studied. The purification was performed by precipitating the proteins of the supernatant fraction obtained after centrifugation of sonicated cells. The resulting proteins were submitted to a gel filtration step followed by DEAE-Sephadex ion exchange chromatography and then by another gel filtration process. The purified amidase had a molecular weight of 180,000 and was composed of four subunits of the same molecular weight (43,000 2,000). Its isoelectric point was 3.5. This enzyme was able to hydrolyze a large number of amides into their corresponding organic acids and it also possessed an acyl transferase activity.Amidases, and especially microbial amidases, have been extensively studied (CLARKE 1970). These enzymes seem t o be very wide spread among protists: bacteria (CLARKB The Brevibacterium sp. R 312 strain is able to transform all sufficiently water-soluble iiitriles into the corresponding organic acids with their amides as an intermediary step (ARNAUD et al. 1976 a, b and c).Two mutant strains were isolated from the Brevibacterium sp. R 312 wild type strain:Brevibacterium sp. 19 is no longer able to hydrate nitriles into amides; it retains, however, an amidase activity similar to the wild type (BUI et al. 1984a); Brevibacterium sp. A4 has a nitrile-hydratase activity identical to that of the R 312 strain, but does no longer hydrolyze most amides into corresponding organic acids ( JALLAGEAS et al. . The isolation of these two mutant strains conclusively demonstrated that two wide spectrum enzymes are involved in the metabolism of nitriles by the Brevibacterium sp.
R 312 strain:-a nitrile-hydratase which transforms nitriles into amides.-an amidase which hydrolyzes amides into their corresponding organic acids.Besides the Brevibacteriurn sp. R 312, Arthrobacter sp. J-1 (YAMADA et al. , ASANO et al. 1980, 1982a was reported recently as one of the very few microorganisms possessing both kinds of enzymes.
20'
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.